|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1000 CAD | +11.11% |
|
+11.11% | - |
| 06-25 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
D&A | 1.11M | 1.01M | 716K | 348K | 430K | |||||
Net Income | -24.77M | -3.61M | -16.74M | -7.64M | -7.77M | |||||
EBT | -24.76M | -3.59M | -16.73M | -7.62M | -7.76M | |||||
CAPEX | -877K | -450K | - | - | -9K | |||||
Income Tax Expense | 12K | 18K | 15K | 14K | 11K | |||||
Interest Expense | -700K | -1.64M | -1.81M | -85K | -4.2M | |||||
Total Assets | 9.98M | 8.12M | 6.52M | 7.34M | 7.95M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -24.77M | -3.61M | -16.74M | -7.64M | -7.77M | |||||
EBT | -24.76M | -3.59M | -16.73M | -7.62M | -7.76M | |||||
CAPEX | -877K | -450K | - | - | -9K | |||||
D&A | 1.11M | 1.01M | 716K | 348K | 430K | |||||
Income Tax Expense | 12K | 18K | 15K | 14K | 11K | |||||
Interest Expense | -700K | -1.64M | -1.81M | -85K | -4.2M | |||||
Total Assets | 9.98M | 8.12M | 6.52M | 7.34M | 7.95M |
- Stock Market
- Stocks
- RVX Stock
- Financials Resverlogix Corp.
- Business Segments
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
